[Elsevier] Fixed-dose combination of obicetrapib and ezetimibe for LDL cholesterol reduction (TANDEM): a phase 3, randomised, double-blind, placebo-controlled trial

Yang0412 Post time The day before yesterday 12:38 | Show all posts |Read mode
This post will be closed automatically in 2026-10-30 12:33
Reward30points


Fixed-dose combination of obicetrapib and ezetimibe for LDL cholesterol reduction (TANDEM): a phase 3, randomised, double-blind, placebo-controlled trial

Authors: Ashish Sarraju, MDa ∙ Danielle Brennan, MSa ∙ Kierstyn Hayden, MPHa ∙ Amanda Stronczek, MPHb ∙ Prof Anne C Goldberg, MDc ∙ Prof Erin D Michos, MD MHSd ∙ Prof Darren K McGuire, MDe ∙ Denise Mason, BSNa ∙ Grace Tercek, MSa ∙ Prof Stephen J Nicholls, MBBS PhDf ∙ Douglas Kling, MBAb ∙ Annie L Neild, PhDb ∙ John Kastelein, MD PhDb ∙ Michael Davidson, MDb ∙ Marc Ditmarsch, MDb ∙ Prof Steven E Nissen, MD

Journal: The Lancet

Volume 405, Issue 10491


p1757-1768


May 17, 2025

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
TJ0695 Post time The day before yesterday 12:38 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    5960


Daily Top Contributors

Return to the list